Azucena Aldaz
- Oncology
- Molecular Biology
- Pediatrics, Perinatology and Child Health top 10%
- Public Health, Environmental and Occupational Health
- Pharmacology top 10%
- Co-authors
- J. GiráldezAna OrtegaEmiliano CalvoC. ViteriLuis SierrasesúmagaMaría J. Blanco‐PrietoCarlos Rodríguez‐NogalesPatrick Couvreur
- Topics
- Antibiotics Pharmacokinetics and Efficacy (9 papers)Colorectal Cancer Treatments and Studies (7 papers)Pharmacological Effects and Toxicity Studies (7 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaACS Nano
- Partner nations
- SpainUnited StatesTanzania
In The Last Decade
Azucena Aldaz
47 papers receiving 744 citations
Peers
Comparison fields: 5 of 111
- Oncology 211
- Molecular Biology 162
- Pediatrics, Perinatology and Child Health 122
- Public Health, Environmental and Occupational Health 118
- Pharmacology 116
Countries citing papers authored by Azucena Aldaz
This map shows the geographic impact of Azucena Aldaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Azucena Aldaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Azucena Aldaz more than expected).
Fields of papers citing papers by Azucena Aldaz
This network shows the impact of papers produced by Azucena Aldaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Azucena Aldaz. The network helps show where Azucena Aldaz may publish in the future.
Co-authorship network of co-authors of Azucena Aldaz
This figure shows the co-authorship network connecting the top 25 collaborators of Azucena Aldaz. A scholar is included among the top collaborators of Azucena Aldaz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Azucena Aldaz. Azucena Aldaz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 7 | |
| 5 | 46 | |
| 6 | 64 | |
| 7 | 8 | |
| 8 | 1 | |
| 9 | 4 | |
| 10 | 25 | |
| 11 | 16 | |
| 12 | 4 | |
| 13 | 16 | |
| 14 | 20 | |
| 15 | 9 | |
| 16 | 52 | |
| 17 | 30 | |
| 18 | 51 | |
| 19 | 3 | |
| 20 | 6 |
About Azucena Aldaz
Azucena Aldaz is a scholar working on Applied Microbiology and Biotechnology, Geriatrics and Gerontology and Oncology, having authored 50 papers that have together received 772 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (9 papers), Colorectal Cancer Treatments and Studies (7 papers) and Pharmacological Effects and Toxicity Studies (7 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (31 citations), Oncology (211 citations) and Pharmacology (116 citations). Azucena Aldaz has collaborated with scholars based in Spain, United States and Tanzania. Frequent co-authors include J. Giráldez, Ana Ortega, Emiliano Calvo, C. Viteri, Luis Sierrasesúmaga, María J. Blanco‐Prieto, Carlos Rodríguez‐Nogales, Patrick Couvreur, Carlos Chaccour and B Poulsen Nautrup. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and ACS Nano.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.